DCGI

reddy's labs

Dr Reddy’s Asked To Resubmit Application for Trials of Russian COVID-19 Vaccine

Payal Banerjee 06/10/2020

The firm has been asked to provide some other...

reddy's labs

Dr Reddy’s Seeks DCGI Nod for Phase-3 Clinical Trial of Russia’s COVID-19 Vaccine

Payal Banerjee 03/10/2020

The Indian pharma giant has collaborated with the Russian...

pexels-anna-shvets-3683118-glitched-31-07-2020-07-00-15

Itolizumab for COVID-19: Who Benefits When the Drug Regulator Is Opaque?

Anupam Kumar Singh and Dinesh Thakur 31/07/2020

It's not clear how the Drug Controller General of...

person-holding-injection-3825529

There Are More Questions We Need to Ask About the COVAXIN Clinical Trials

Aakash Sethi and Gayatri Laha 08/07/2020

While the approval of the drug or the vaccine...

FILE PHOTO: An ampule of Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg

Generic Version of Remdesivir to Be Launched in India at Rs 4,800 per 100 mg Vial

Reuters 06/07/2020

Mylan's version comes after two Indian drugmakers, Cipla Ltd...

medicines_Reuters

Government Notifies New Rules for Drugs and Clinical Trials

"The aim is to promote clinical research in India,...

generic-medicines

New Government Report Affirms India’s Patient-First Commitment on Pharma Patents

Anoo Bhuyan 07/03/2018

A government review says it is well within its...